Patents by Inventor Mei-Li Wu

Mei-Li Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11834647
    Abstract: The present invention relates to an in vitro immune synapse system and a method of in vitro evaluating immune response using the same. The in vitro immune synapse system includes antigen-presenting cells (APCs) and at least one cell type of several specific T cell subtypes isolated from peripheral blood mononuclear cells (PBMCs), all of which is from a same individual of pigs. When a test sample is co-cultured in the in vitro immune synapse system for a given period, it can be determined that the test sample is immunogenic, immunostimulatory or not according to the immunization-related changes of these cells, thereby potentially replacing some kinds of animal experimentation.
    Type: Grant
    Filed: September 15, 2020
    Date of Patent: December 5, 2023
    Assignee: National Pingtung University of Science and Technology
    Inventors: Hso-Chi Chaung, Wen-Bin Chung, Ann Ying-An Chen, Mei-Li Wu
  • Publication number: 20230074637
    Abstract: The present invention relates to a recombinant antigen and an isolated polynucleotide of porcine reproductive and respiratory syndrome virus (PRRSV), a composition including the same and a method of making the same. The recombinant antigen is a chimeric protein of PRRSV dual structural proteins and T-cell epitope. The polynucleotide encodes an amino acid sequence of the recombinant antigen. The recombinant protein expressed by the polynucleotide in an eukaryotic expression system can be beneficial for mass production and purification. An immunogenic composition including the recombinant antigen can promote pro-inflammatory M1-phenotype polarization of porcine alveolar macrophages (PAMs), reduce receptor CD163 expression that is mediated for viral entry and activate T helper (Th1) immune responses, thereby being applied to a vaccine composition against PRRSV.
    Type: Application
    Filed: September 7, 2022
    Publication date: March 9, 2023
    Inventors: Hso-Chi Chaung, Ko-Tung Chang, Mei-Li Wu, Wen-Bin Chung
  • Publication number: 20200407683
    Abstract: The present invention relates to an in vitro immune synapse system and a method of in vitro evaluating immune response using the same. The in vitro immune synapse system includes antigen-presenting cells (APCs) and at least one cell type of several specific T cell subtypes isolated from peripheral blood mononuclear cells (PBMCs), all of which is from a same individual of pigs. When a test sample is co-cultured in the in vitro immune synapse system for a given period, it can be determined that the test sample is immunogenic, immunostimulatory or not according to the immunization-related changes of these cells, thereby potentially replacing some kinds of animal experimentation.
    Type: Application
    Filed: September 15, 2020
    Publication date: December 31, 2020
    Inventors: Hso-Chi Chaung, Wen-Bin Chung, Ann Ying-An Chen, Mei-Li Wu
  • Publication number: 20200190471
    Abstract: The present invention relates to an in vitro immune synapse system and a method of in vitro evaluating immune response using the same. The in vitro immune synapse system includes antigen-presenting cells (APCs) and at least one cell type of several specific T cell subtypes isolated from peripheral blood mononuclear cells (PBMCs), all of which is from a same individual of pigs. When a test sample is co-cultured in the in vitro immune synapse system for a given period, it can be determined that the test sample is immunogenic, immunostimulatory or not according to the immunization-related changes of these cells, thereby potentially replacing some kinds of animal experimentation.
    Type: Application
    Filed: December 13, 2018
    Publication date: June 18, 2020
    Inventors: Hso-Chi Chaung, Wen-Bin Chung, Ann Ying-An Chen, Mei-Li Wu
  • Patent number: 10117929
    Abstract: The present invention relates to a nucleic acid-based adjuvant and a porcine vaccine composition including the same. The nucleic acid-based adjuvant, which is a nucleic acid fragment consisting of a sequence listing as SEQ ID NO: 1, can be used as the nucleic acid-based adjuvant of a vaccine composition, thereby elevating the protective ability of the porcine vaccine composition.
    Type: Grant
    Filed: November 23, 2017
    Date of Patent: November 6, 2018
    Assignee: National Pingtung University of Science and Technology
    Inventors: Hso-Chi Chaung, Guan-Ming Ke, Mei-Li Wu
  • Patent number: 9441015
    Abstract: The present invention is directed to a recombinant fusion antigen gene, a recombinant fusion antigen protein and a subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus (PRRSV). A recombinant fusion antigen gene, which encodes glycoprotein GP5 with truncated N?-terminal decoy epitope, a linker sequence and membrane protein M, followed by codon optimization, is expressed by a baculovirus expression system in vitro, thereby enhancing a yield of the recombinant fusion antigen protein. The recombinant fusion antigen protein can be applied in a subunit vaccine composition, for providing vaccinated animals with better protection ability without the risks of virulent spread and virulent recovery.
    Type: Grant
    Filed: March 25, 2015
    Date of Patent: September 13, 2016
    Assignee: NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Mei-Li Wu, Hso-Chi Chaung, Guan-Ming Ke
  • Publication number: 20160137699
    Abstract: The present invention is directed to a recombinant fusion antigen gene, a recombinant fusion antigen protein and a subunit vaccine composition having the same against infection of porcine reproductive and respiratory syndrome virus (PRRSV). A recombinant fusion antigen gene, which encodes glycoprotein GP5 with truncated N?-terminal decoy epitope, a linker sequence and membrane protein M, followed by codon optimization, is expressed by a baculovirus expression system in vitro, thereby enhancing a yield of the recombinant fusion antigen protein. The recombinant fusion antigen protein can be applied in a subunit vaccine composition, for providing vaccinated animals with better protection ability without the risks of virulent spread and virulent recovery.
    Type: Application
    Filed: March 25, 2015
    Publication date: May 19, 2016
    Inventors: Mei-Li WU, Hso-Chi CHAUNG, Guan-Ming KE
  • Patent number: 8008031
    Abstract: The present invention provides a method for detecting a beta-glucan having immunomodulatory activity in a human cell, which uses a test cell line that stably expresses human dectin-1 molecule on the cell surface and does not express other glucan receptors and a specific amount of a marker beta-glucan that specifically binds to human dectin-1 molecule for detection.
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: August 30, 2011
    Assignee: National Pingtung University of Science and Technology
    Inventors: Mei-Li Wu, Hso-Chi Chaung, Tzou-Chi Huang, Wen-Bin Chung, Hui-Ju Hung
  • Publication number: 20090162872
    Abstract: The present invention provides a method for detecting a beta-glucan having immunomodulatory activity in a human cell, which uses a test cell line that stably expresses human dectin-1 molecule on the cell surface and does not express other glucan receptors and a specific amount of a marker beta-glucan that specifically binds to human dectin-1 molecule for detection.
    Type: Application
    Filed: December 19, 2007
    Publication date: June 25, 2009
    Inventors: Mei-Li WU, Hso-Chi CHAUNG, Tzou-Chi HUANG, Wen-Bin CHUNG, Hui-Ju HUNG
  • Publication number: 20030150248
    Abstract: A cylindrical door lock includes an escutcheon member having a sleeve, a tube rotatably engaged in the sleeve, a knob rotatably secured to the sleeve and having a lock device, a barrel rotatably received in the escutcheon member and having one or more projections for engaging into the tube, an inner knob secured to the barrel, a rod slidably engaged in the inner knob and having two depressions, a spring catch engaged on the barrel and having two legs for selectively engaging with the depressions of the rod and for selectively locking the barrel to the rod.
    Type: Application
    Filed: February 14, 2002
    Publication date: August 14, 2003
    Inventors: Mei Li Wu, Kuo Chih Hsia, Chie Gau, Yi Hsiung Chao, Kung Da Huang